Which Probiotics Are Best for IBS? What the Trials Tested

No single live culture is "best" for IBS. Across 82 randomised trials in 10,332 people, some species and mixtures improved overall symptoms and pain, but the certainty was low to very low for almost every comparison, and no trial has compared the products on sale.¹ UK guidance is practical: NICE says take one product for at least four weeks and judge the effect.² This page is one spoke of the Wellgard probiotics guide; the condition itself is covered in understanding IBS.

Evidence at a glance

• Trials: 82 randomised trials pooled in 2023, 10,332 people with IBS; 52 double-blind trials, 6,289 people, in a second 2023 pooling.
• Largest single trial: 362 women with IBS, four weeks, three doses of one bifidobacterium strain against placebo.
• Strongest measured outcome: overall response 1.64 times as likely as on placebo across the 52 double-blind trials; pain relief 1.69 times.
• Not yet tested: no trial has compared the products sold in UK shops with one another; no pooled analysis separates IBS-M or IBS-U.

Sources checked on 16 October 2026.

Which probiotics are best for IBS?

The ones that were tested, at the dose that was tested; "best" has no other meaning here. The 2023 review of 82 trials graded the evidence by strain. For overall symptoms, there was moderate certainty of a benefit for Escherichia coli strains, low certainty for Lactobacillus strains including one Lactobacillus plantarum strain, and very low certainty for combinations and Bacillus strains. For abdominal pain, low certainty for one Saccharomyces cerevisiae strain and for Bifidobacterium strains. For bloating, very low certainty throughout.¹

A 2023 network analysis of 81 trials (9,253 people) ranked them: four single strains and five mixtures beat placebo on symptom severity, with a Lactobacillus acidophilus strain first for severity and two Bacillus coagulans strains for pain. Rankings are probabilities of coming top, not sizes of effect.³ A 2026 strain-by-strain pooling of 32 trials found efficacy for one strain each of Bifidobacterium longum, Lactobacillus rhamnosus, L. plantarum, S. cerevisiae and B. coagulans, none for an E. coli, a L. gasseri or a L. casei strain, and conflicting results for the yeast Saccharomyces boulardii.⁴ The two reviews disagree about E. coli, which is the point: the result belongs to the strain and the trial, not to the species name on a label.

Do probiotics help with IBS?

Some do, modestly, in some trials. Across 52 double-blind placebo-controlled trials (6,289 people), live cultures made an overall response 1.64 times as likely and relief of abdominal pain 1.69 times as likely; the benefit appeared at 1 billion CFU a day or more and was present from four weeks.⁵ In 214 people with IBS taking one L. plantarum strain for four weeks, pain and bloating were lower than on placebo, and 78.1% rated the effect excellent or good against 8.1%.⁶ The null results matter as much. In 123 people with IBS taking a Bifidobacterium lactis strain, a Bacillus coagulans strain or placebo for twelve weeks, symptom scores fell in every group, placebo included, and did not differ between groups while the capsules were taken; at the four-week follow-up, 43.8% and 52.9% had improved against 20.5%. The authors had ties to the manufacturer.⁷

What does UK guidance say about trying probiotics for IBS?

NICE's IBS guideline, recommendation 1.2.1.6: "People with IBS who choose to try probiotics should be advised to take the product for at least 4 weeks while monitoring the effect. Probiotics should be taken at the dose recommended by the manufacturer" (recommendation dated 2008; guideline last updated 4 April 2017).² The NHS IBS page says "try probiotics for a month" (page last reviewed 17 March 2025).⁸ The dose rule has a trial behind it. In 362 women with IBS, one bifidobacterium strain at 100 million CFU a day beat placebo on pain, bloating and bowel function over four weeks; 1 million did not, and nor did 10 billion, because the high-dose capsule had formulation problems.⁹ If nothing has changed after four weeks, that product has had its trial; other outcomes are timed on how long probiotics take to work.

Which species were tested for each type of IBS?

Most trials recruited people with any IBS type, so subtype answers are thin. The four types are IBS-D (diarrhoea), IBS-C (constipation), IBS-M (mixed) and IBS-U (unclassified).

Do probiotics help bloating?

The weakest of the IBS outcomes. The 82-trial review found very low certainty of a benefit for bloating, from combinations and Bacillus strains.¹ The one trial built around bloating: 60 people with functional bowel disorders (33 with IBS) took a two-strain capsule of Lactobacillus acidophilus and Bifidobacterium lactis twice a day or placebo for eight weeks; bloating scores were 4.10 against 6.17 at four weeks (P = 0.009) and 4.26 against 5.84 at eight (P = 0.06). It was supplier-funded, with one author employed by the supplier.¹⁰ The fibre side is on which fibre is best for IBS.

Can probiotics make IBS worse?

No pooled analysis records it. Across 55 trials with more than 7,000 people, adverse events were not significantly more common on live cultures than on placebo¹, and the twelve-week three-arm trial found no difference in adverse events.⁷ Wind and looser stools in the first days are the recorded side effects, and in a gut that over-reacts they can feel like a flare. If a product makes things worse for more than a week or two, stop it; the NHS says to see a GP if "diet changes and pharmacy medicines are not helping your IBS symptoms".⁸

What else has evidence for IBS?

The NHS list comes first: a balanced diet, a diary of food and symptoms, 8 to 10 drinks of fluid a day, ways to relax, exercise; no skipped meals, no eating quickly, not "lots of fatty, spicy or processed foods". For bloating and cramps it adds oats and up to a tablespoon of linseeds a day; for constipation, soluble fibre; for diarrhoea, cutting high-fibre wholegrains and sorbitol.⁸ NICE says the same about fibre: discourage insoluble fibre such as bran, and use soluble fibre such as ispaghula if more is needed; what psyllium does is on what psyllium husk does. If symptoms persist, NICE says exclusion diets such as a low-FODMAP diet should "only be given by a healthcare professional with expertise in dietary management".²

What we don't know

• No trial has compared the products sold in UK shops with one another, so no product can be called best.
• No pooled analysis separates IBS-M or IBS-U, and the IBS-C evidence rests on one arm of one trial.
• Only 24 of the 82 trials were at low risk of bias; several positive single-strain trials were supplier-run or supplier-funded.
• No trial tells a person whose symptoms have not changed at four weeks whether a different strain would do better.

Frequently asked questions

Which probiotic is best for IBS-D or IBS-C?

For IBS-D, four single strains and one mixture reduced bowel frequency, with a Bacillus coagulans and a Saccharomyces cerevisiae strain ranked highest for stool form.³ For IBS-C, one Bifidobacterium lactis strain reduced the number of people with constipation after six weeks in a 123-person trial.⁷ Neither is a product recommendation; the strain and dose on the label have to match what was tested.

How long do probiotics take to work for IBS?

Four weeks is the judging point: the pooled benefit was present from four weeks, NICE says at least four, and in one twelve-week trial the difference from placebo appeared only at follow-up.^{2, 5, 7}

How long do probiotics take to reduce bloating?

Four weeks in the one trial built around bloating, with a smaller difference at eight.¹⁰ If nothing has changed after a month, NICE's rule applies.²

What helps IBS immediately?

Nothing on this page works in an afternoon; the trials are measured in weeks. For a flare, the NHS route is a pharmacist: antispasmodic medicines or peppermint oil for cramps and wind, loperamide for diarrhoea, laxatives for constipation. See a GP if those are not helping.⁸

Sources

1. Goodoory VC, et al. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gastroenterology, 2023. Pooled analysis of 82 randomised trials, 10,332 people with IBS; adverse events from 55 trials. PubMed 37541528.
2. NICE. Irritable bowel syndrome in adults: diagnosis and management, clinical guideline CG61, recommendations 1.2.1.5 to 1.2.1.8. nice.org.uk. Published 23 February 2008; last updated 4 April 2017.
3. Xie P, et al. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Nutrients, 2023. Network meta-analysis of 81 randomised trials, 9,253 people. PubMed 37686889.
4. Maslennikov R, et al. Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome. Journal of Clinical Medicine, 2026. Pooled analysis of 32 articles, 10 strains. PubMed 41682832.
5. Zhang WX, et al. Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials. Journal of Medical Microbiology, 2023. Pooled analysis of 52 double-blind trials, 6,289 people. PubMed 37772692.
6. Ducrotté P, Sawant P, Jayanthi V. World Journal of Gastroenterology, 2012 (a Lactobacillus plantarum strain in IBS). Randomised double-blind trial, 214 people, 4 weeks; funding not checked. PubMed 22912552.
7. Skrzydło-Radomańska B, et al. The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome. Journal of Clinical Medicine, 2023. Randomised double-blind three-arm trial, 123 people, 12 weeks plus 4 weeks' follow-up; authors with ties to the manufacturer. PubMed 37510953.
8. NHS. Diet, lifestyle and medicines for IBS (irritable bowel syndrome). nhs.uk. Page last reviewed 17 March 2025.
9. Whorwell PJ, et al. American Journal of Gastroenterology, 2006 (an encapsulated bifidobacterium strain in women with IBS). Randomised dose-ranging trial, 362 women, 4 weeks; funding not checked. PubMed 16863564.
10. Ringel-Kulka T, et al. Journal of Clinical Gastroenterology, 2011 (a two-strain lactobacillus and bifidobacterium capsule for bloating in functional bowel disorders). Randomised double-blind trial, 60 people, 8 weeks; supplier-funded, one author employed by the supplier. PubMed 21436726.

Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.